ALZAMEND NEURO, INC. (ALZN) Operating income 2020–2026
ALZAMEND NEURO, INC. (ALZN) annual operating income history from SEC filings — each fiscal year as reported.
-$8.8MFY2026 · since FY2020: -$4.4M → -$8.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$8.8M | -95.0% |
| FY2025 | -$4.5M | +54.7% |
| FY2024 | -$9.9M | +33.2% |
| FY2023 | -$14.9M | -20.7% |
| FY2022 | -$12.3M | -148.8% |
| FY2021 | -$5.0M | -11.9% |
| FY2020 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALZN financial trends
ALZN RevenueALZN Net incomeALZN Net marginALZN Gross profitALZN Gross marginALZN Operating marginALZN Operating cash flowALZN Free cash flowALZN Capital expendituresALZN Return on equityALZN Stock buybacksALZN Dividends paidALZN Total assetsALZN Total liabilitiesALZN Shareholders’ equityALZN overview →